Trial Profile
Dietary Treatment of Glucose Transporter Type 1 Deficiency (G1D)
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 01 Feb 2024
Price :
$35
*
At a glance
- Drugs Triheptanoin (Primary)
- Indications De Vivo disease
- Focus Therapeutic Use
- 24 Jan 2024 Planned End Date changed from 30 Sep 2023 to 30 Sep 2024.
- 24 Jan 2024 Planned primary completion date changed from 30 Sep 2023 to 30 Sep 2024.
- 28 Apr 2023 Planned End Date changed from 30 May 2023 to 30 Sep 2023.